Lymphomas
A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared with Ibrutinib in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (BGB-3111-305)
- Details
ClinicalTrials.gov ID:
NCT03734016
Diagnosis Type:
NA
USOR Number:
- Address
7777 Forest Lane, Suite D400
Dallas, TX 75230
P: (972) 566-6647